Your browser doesn't support javascript.
loading
An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States.
Wong, Robert J; Brosgart, Carol L; Welch, Sue; Block, Tim; Chen, Mark; Cohen, Chari; Kim, W Ray; Kowdley, Kris V; Lok, Anna S; Tsai, Naoky; Ward, John; Wong, Steven S; Gish, Robert G.
Afiliación
  • Wong RJ; Division of Gastroenterology and HepatologyStanford University School of MedicineStanfordCA.
  • Brosgart CL; Division of Gastroenterology and HepatologyVeterans Affairs Palo Alto Healthcare SystemPalo AltoCA.
  • Welch S; Department of Medicine, Epidemiology and BiostatisticsUniversity of CaliforniaSan FranciscoCA.
  • Block T; Plan A, Inc.Mountain ViewCA.
  • Chen M; Hepatitis B FoundationDoylestownPA.
  • Cohen C; Baruch S Blumberg InstituteDoylestownPA.
  • Kim WR; Plan A, Inc.Mountain ViewCA.
  • Kowdley KV; Hepatitis B FoundationDoylestownPA.
  • Lok AS; Baruch S Blumberg InstituteDoylestownPA.
  • Tsai N; Division of Gastroenterology and HepatologyStanford University School of MedicineStanfordCA.
  • Ward J; Liver Institute NorthwestSeattleWA.
  • Wong SS; Division of Gastroenterology and HepatologyUniversity of MichiganAnn ArborMI.
  • Gish RG; University of HawaiiHonoluluHI.
Hepatology ; 74(2): 607-626, 2021 08.
Article en En | MEDLINE | ID: mdl-33655536
BACKGROUND AND AIMS: Although prevalence of chronic hepatitis B (CHB) in the USA includes 0.42 million (range, 0.28-0.67) U.S.-born persons, foreign-born (FB) persons contribute a substantially larger number to the burden of CHB in the USA. Over the past decade, patterns of U.S. immigration have changed and many countries have implemented HBV prevention programs. This study aims to estimate the number of FB persons with CHB in the USA by country of origin, updating our 2011 study. APPROACH AND RESULTS: We performed systematic searches for articles published in 2009-2019 reporting HBsAg seroprevalence in emigrants and in-country populations of 117 countries. Data meeting inclusion criteria were combined with data from our 2011 study to calculate pooled prevalence estimates for 99 countries using meta-analyses (total 2,800 surveys involving 112 million subjects). Combining country-specific CHB rate estimates with the number of FB in the USA in 2018, by country of origin from the U.S. Census Bureau, we estimate that the number of FB with CHB in the USA in 2018 was 1.47 million (95% CI, 1.21-1.73), substantially higher than previously reported. The weighted average CHB prevalence for all FB in the USA in 2018 was 3.07%. Approximately 59% of FB with CHB in the USA in 2018 emigrated from Asia, 19% from the Americas, and 15% from Africa. Subgroup analyses found that for many countries, CHB rates are higher in males than females and have declined over the past three decades, but no consistent pattern is observed between emigrant and in-country rates. CONCLUSIONS: Including FB and U.S.-born persons, the total prevalence of CHB in the USA may be as high as 2.4 million.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatitis B Crónica / Emigrantes e Inmigrantes Tipo de estudio: Prevalence_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Hepatology Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatitis B Crónica / Emigrantes e Inmigrantes Tipo de estudio: Prevalence_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Hepatology Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos